Changes of neuromuscular transmission in smooth muscles of rats bladder with experimental diabetes
Vladimirova IA1, Filippov IB1, Paduraru ON2, Shuba ÉIa1, Kuliieva ÉM1, Shuba IaM1,2,3
- Bogomoletz Institute of physiology NAS of Ukraine, Kyiv;
- International Center for Molecular Physiology, Kyiv, Ukraine
- State key Laboratory of Molecular. and cells. physiology, Kyiv
DOI: https://doi.org/10.15407/fz60.02.031
Abstract
Literary data show that in patients with sugar-
nerve regulation of visceral smooth
muscle is broken. We investigated the contribution of cholinergic
and purinergic components of neuromuscular
transmission in the reduction of strips of smooth muscle detrusora
(HMD) of control rats and rats with streptozotocininduci-
diabetes mellitus in response to electrical
stimulation, and the application of exogenous carba-
cholesterol (KX, 1 μmol / L) and ATP (1 mmol / L). We managed to
two types of contractile reactions of the KMD patients
animals. The first type, which occurred in 80% of all
studied strips of diabetic rats, characterized by
The absence of changes in the amplitude and kinetics
synaptic-induced abbreviations and effects on
CX application, but the strengthening of the contractile response to
application of exogenous ATP in comparison with the control.
The second type of reaction, observed in the remaining 20%
drugs, was to increase the duration
synaptic-induced contractions due to greater
contribution to them cholinergic component, statistically
significant increase in response to exogenous
CX and even greater reductions in the application
exogenous ATP in comparison with the control. Our results
to some extent explain the differences in literary
data on the impact of experimental diabetes on
neuromuscular transmission in the KMD. Establishing reasons
revealed heterogeneity of synaptic transmission at
diabetes require further research.
Keywords:
diabetes, bladder, smooth- Muscle, contraction, neuromuscular transmission.
References
- Vinik AI, Freeman R, Erbas T. Diabetic autonomic neuropathy. Semin Neurol. 2003 Dec;23(4):365-72.
CrossRef
PubMed
- Daneshgari F, Liu G, Birder L, Hanna-Mitchell AT, Chacko S. Diabetic bladder dysfunction: current translational knowledge. J Urol. 2009 Dec;182(6 Suppl):S18-26.
CrossRef
PubMed PubMedCentral
- Latifpour J, Gousse A, Kondo S, Morita T, Weiss RM. Effects of experimental diabetes on biochemical and functional characteristics of bladder muscarinic receptors. J Pharmacol Exp Ther. 1989 Jan;248(1):81-8.
PubMed
- Luheshi GN, Zar MA. The effect of streptozotocin-induced diabetes on cholinergic motor transmission in the rat urinary bladder. Br J Pharmacol. 1991 Jul;103(3):1657-62.
CrossRef
PubMed PubMedCentral
- Hegde SS, Eglen RM. Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder. Life Sci. 1999;64(6-7):419-28.
CrossRef
- Andersson KE, Yoshida M. Antimuscarinics and the overactive detrusor--which is the main mechanism of action? Eur Urol. 2003 Jan;43(1):1-5.
CrossRef
- Agarwal VR, Rastogi AK, Sahib MK, Sagar P. In vitro insulin effect on acetylcholine esterase of erythrocyte membranes of normal and diabetic rats. Acta Diabetol Lat. 1985 Oct-Dec;22(4):359-63.
CrossRef
PubMed
- Liu G, Daneshgari F. Alterations in neurogenically mediated contractile responses of urinary bladder in rats with diabetes. Am J Physiol Renal Physiol. 2005 Jun;288(6):F1220-6.
CrossRef
PubMed
- Mumtaz FH, Lau DH, Siddiqui EJ, Morgan RJ, Thompson CS, Mikhailidis DP. Changes in cholinergic and purinergic neurotransmission in the diabetic rabbit bladder. In Vivo. 2006 Jan-Feb;20(1):1-4.
PubMed
- de Groat WC, Yoshimura N. Pharmacology of the lower urinary tract. Annu Rev Pharmacol Toxicol. 2001;41:691-721.
CrossRef
PubMed
- Ford AP, Gever JR, Nunn PA, Zhong Y, Cefalu JS, Dillon MP, Cockayne DA. Purinoceptors as therapeutic targets for lower urinary tract dysfunction. Br J Pharmacol. 2006Feb;147 Suppl 2:S132-43. Andersson KE, Persson K. Nitric oxide synthase and nitric oxide-mediated effects in lower urinary tract smooth muscles. World J Urol. 1994;12(5):274-80. Review.
- Rosamilia A, Dwyer PL. Pathophysiology of interstitial cystitis. Curr Opin Obstet Gynecol. 2000 Oct;12(5):405-10.
CrossRef
PubMed
- Brooks BA, Goll DE, Peng YS, Greweling JA, Hennecke G. Effect of alloxan diabetes on a Ca2+-activated proteinase in rat skeletal muscle. Am J Physiol. 1983 Mar;244(3):C175-81.
CrossRef
PubMed
- Song RH, Singh AK, Leehey DJ. Decreased glomerular proteinase activity in the streptozotocin diabetic rat. Am J Nephrol. 1999;19(3):441-6.
CrossRef
PubMed
- Zambotti-Villela L, Yamasaki SC, Villarroel JS, Murena- Nunes C, Silveira PF. Prolyl, cystyl and pyroglutamyl peptidase activities in the hippocampus and hypothalamus of streptozotocin-induced diabetic rats. Peptides. 2007 Aug;28(8):1586-95.
CrossRef
PubMed
- Wolinsky H, Goldfischer S, Capron L, Capron F, Coltoff- Schiller B, Kasak L. Hydrolase activities in the rat aorta. I. Effects of diabetes mellitus and insulin treatment. CircRes. 1978 Jun;42(6):821-31.
CrossRef
PubMed
- Patel BN, Mackness MI, Harty DW, Arrol S, Boot- Handford RP, Durrington PN. Serum esterase activities and hyperlipidaemia in the streptozotocin-diabetic rat. Biochim Biophys Acta. 1990 Jul 20;1035(1):113-6.
CrossRef
|